Marksans Pharma consolidated net profit rises 63.59% in the March 2026 quarter

Sales rise 20.84% to Rs 856.11 crore

Net profit of Marksans Pharma rose 63.59% to Rs 148.13 crore in the quarter ended March 2026 as against Rs 90.55 crore during the previous quarter ended March 2025. Sales rose 20.84% to Rs 856.11 crore in the quarter ended March 2026 as against Rs 708.46 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.81% to Rs 417.90 crore in the year ended March 2026 as against Rs 380.58 crore during the previous year ended March 2025. Sales rose 12.51% to Rs 2950.94 crore in the year ended March 2026 as against Rs 2622.85 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	856.11	708.46	21	2950.94	2622.85	13
OPM %	22.83	17.92	-	20.36	20.31	-
PBDT	224.29	138.84	62	659.19	587.35	12
PBT	200.00	116.09	72	560.56	503.97	11
NP	148.13	90.55	64	417.90	380.58	10

Powered by Capital Market - Live News